Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152591 | SCV000201861 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Val2979Val in Exon 45 of USH2A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.9% (33/3738) of Af rican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs139100097). |
Prevention |
RCV000152591 | SCV000317215 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000152591 | SCV000339955 | benign | not specified | 2016-04-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000756883 | SCV000714995 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000152591 | SCV000884850 | benign | not specified | 2018-08-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000756883 | SCV001105409 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453120 | SCV004182751 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453119 | SCV004182752 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000152591 | SCV001920738 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000756883 | SCV001975941 | likely benign | not provided | no assertion criteria provided | clinical testing |